Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial) - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Safety and effectiveness of the ranibizumab port delivery system for diabetic macular oedema: the PAGODA randomized clinical trial

  • By

  • Shamika Gune

  • Mel Rabena

  • Ashwini Bobbala

  • October 8, 2026

Share

Original Source(s)

Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial)

  • by Shamika Gune, Mel Rabena, Ashwini Bobbala

  • October 8, 2026

Related Content

Data and Temporal Risk Concerns of Semaglutide and NAION—Reply

Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage

Error in Figure 1

  • October 1, 2026